Vaccine Manufacture and Supply

The transition from manufacturing vaccines in smaller quantities required for academic research to the mass production that is required to protect the global population can be a daunting task. In this article, we discuss key challenges related to the large-scale production of vaccines and also highlight ways to overcome these.

This infographic provides an overview of vaccine development history, exploring how manufacturing pipelines differ for "traditional" and "new-era" vaccines, and how these processes can be accelerated.

This article covers the challenges associated with conventional vaccine approaches and elaborates on some of the recent innovations which can help design better vaccines.

Science writer Anthony King takes a close look at how each of the authorized COVID-19 vaccines are made, and the challenges faced when working to vaccinate the global population.